期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Development of a Handheld Nano-centrifugal Device for Visual Virus Detection 被引量:1
1
作者 Zi-Rong Bi Meng-Lu Hu +6 位作者 Yong-Zhong Jiang er-hu xiong Bo-Wen Shu Si-Qi Li Han-Wei Chen Xiao-Hua Chen Xiao-Ming Zhou 《Journal of Analysis and Testing》 EI 2022年第4期353-364,共12页
Gold nanoparticles(AuNPs)colorimetric assays based on distance-dependent optical characteristics have been widely employed for bioanalysis.However,this assay is not effective for visually detecting low-concentration t... Gold nanoparticles(AuNPs)colorimetric assays based on distance-dependent optical characteristics have been widely employed for bioanalysis.However,this assay is not effective for visually detecting low-concentration targets due to the faint color change.Here,we developed a handheld nano-centrifugal device which could separate the crosslinked and non-crosslinked AuNPs.Results showed that the handheld nano-centrifugal device could easily reach more than 6000 r/min within 10 s simply by stretching and tightening the coiled rope in an appropriate rhythm.Further,combined with the CRISPR/Cas12a nucleic acids recognition system,a field-deployable colorimetric platform termed handheld nano-centrifugal device assisted CRISPR/Cas12a(Hand-CRISPR)has been validated.Moreover,clinical diagnostics applications for Epstein-Barr virus(EBV)and severe acute respiratory syndrome coronavirus-2(SARS-CoV-2)detection with high sensitivity and accuracy(100%consistency with reverse transcription quantitative real-time polymerase chain reaction(RT-qPCR)test results)have been demonstrated.Overall,the Hand-CRISPR platform showed great promise in point-of-care-test(POCT)application,expected to become a powerful supplement to the standard nucleic acid testing method in remote or poverty-stricken areas. 展开更多
关键词 Nucleic acids assay CRISPR/Cas12a Gold nanoparticles Centrifugal device Clinical diagnostics
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部